Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,202

Hiroshima fallout debris linked to first solar system condensates

The atomic bombing of Hiroshima, Japan, by the United States in August 1945 was not only devastating at the time, resulting in the deaths of hundreds of thousands of people, but it has had long-standing impacts to the present day, particularly the elevated incidence of cancer from radiation.

Continued research of Hiroshima Bay has uncovered a new kind of debris from the fallout, known as Hiroshima glasses. These formed from vaporized materials of the bomb and the surrounding landscape and infrastructure being targeted.

New research published in Earth and Planetary Science Letters has analyzed the chemical and isotopic compositions of these glasses to ascertain their formation process during the nuclear event.

Enhanced 3D chemical imaging with phase-modulation

Understanding complex biological and biomedical systems is greatly aided by 3D imaging, which provides much more detailed information than traditional two-dimensional methods. However, live cell and tissue imaging remain challenging due to factors like limited imaging speed and significant scattering in turbid environments.

In this context, multimodal microscopy techniques are notable. Specifically, nonlinear techniques like CRS (coherent Raman scattering) use optical vibrational spectroscopy, providing precise chemical imaging in tissues and cells in a label-free way.

Furthermore, stimulated Raman scattering (SRS) microscopy, a CRS method, can accurately capture images of biomolecules due to the linear relationship between stimulated Raman intensity and the concentration of target molecules. It does so with high sensitivity and without interference from unwanted nonresonant backgrounds.

Evading Bacterial Resistance: Scientists Develop Groundbreaking New Antibiotic

Researchers from the University of Illinois Chicago and Harvard University have created an antibiotic that may provide medicine a new tool to combat bacteria resistant to drugs and the illnesses they trigger.

The antibiotic, cresomycin, described in Science, effectively suppresses pathogenic bacteria that have become resistant to many commonly prescribed antimicrobial drugs.

The promising novel antibiotic is the latest finding for a longtime research partnership between the group of Yury Polikanov, associate professor of biological sciences at UIC, and colleagues at Harvard. The UIC scientists provide critical insights into cellular mechanisms and structure that help the researchers at Harvard design and synthesize new drugs.

Scientists Have Created the World’s Smallest, Lightest, and Fastest Fully Functional Micro-Robots

Two insect-like robots, a mini-bug and a water strider, developed at Washington State University, are the smallest, lightest and fastest fully functional micro-robots ever known to be created.

Such miniature robots could someday be used for work in areas such as artificial pollination, search and rescue, environmental monitoring, micro-fabrication, or robotic-assisted surgery. Reporting on their work in the proceedings of the IEEE Robotics and Automation Society’s International Conference on Intelligent Robots and Systems, the mini-bug weighs in at eight milligrams while the water strider weighs 55 milligrams. Both can move at about six millimeters a second.

Researchers develop molecules for a new class of antibiotics that can overcome drug resistant bacteria

About a decade ago, researchers in UC Santa Barbara chemistry professor Guillermo Bazan’s lab began to observe a recurring challenge in their research: Some of the compounds they were developing to harness energy from bacteria were instead killing the microbes. Not good if the objective of the project was to harness the metabolism of living bacteria to produce electricity.

“We needed the bacteria to be alive,” said Alex Moreland, a Cystic Fibrosis Foundation Postdoctoral Fellow who joined the Bazan research group as a graduate student in 2014, and currently works at UCSB’s Center for Polymers and Organic Solids. “While we were developing new molecules for that application, we found that some of them didn’t work because they were killing the bacteria.”

However, instead of brushing it off as a rather annoying laboratory curiosity, in subsequent research the team leaned into the apparent antimicrobial properties of these compounds, called conjugated oligoelectrolytes (COE). Fast-forward to today, and they now have the basis for a new class of antibiotics, one that not only shows promise against a broad array of bacterial infections but can also evade the dreaded resistance that has been rendering our current generation of first-line antibiotics ineffective.

Bioweapons Designed by AI: a ‘Very Near-Term Concern,’ Schmidt Says

Artificial intelligence could bring about “biological conflict,” said former Google chief executive Eric Schmidt, who co-chaired the National Security Commission on Artificial Intelligence.

Schmidt spoke with defense reporters Sept. 12 as he helped release a new paper from his tech-oriented nonprofit think tank, the Special Competitive Studies Project. Schmidt launched the think tank with staff from the commission in order to continue the commission’s work.

AI’s applicability to biological warfare is “something which we don’t talk about very much,” Schmidt said, but it poses grave risks. “It’s going to be possible for bad actors to take the large databases of how biology works and use it to generate things which hurt human beings,” Schmidt said, calling that risk “a very near-term concern.”

/* */